酸沉积疾病的治疗管理的最新进展
Paraskevi V Voulgari1, Aliki I Venetsanopoulou1, Alexandros A Drosos1
1Department of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
Frontiers in medicine
|March 26, 2024
概括
由于试验有限,酸盐沉积 (CPPD) 疾病的管理具有挑战性. 目前的治疗重点是缓解症状和预防这种水晶诱导的关节病的发作.
科学领域:
- 类风湿病学 类风湿病学
- 结晶诱导的关节病变
- 药理学 药理学是指药理学的学科.
背景情况:
- 聚酸沉积 (CPPD) 疾病涉及关节中的晶体积累,导致炎症和损伤.
- 慢性炎症性关节炎可以表现为无症状或急性/慢性炎症性关节炎.
- 风险因素包括关节损伤,骨关节炎,遗传倾向和代谢性疾病.
研究的目的:
- 审查CPPD目前的药理管理策略.
- 专注于减少炎症,缓解症状和预防急性爆发.
- 为了突出基于证据的治疗的挑战,由于稀疏的随机对照试验.
主要方法:
- 对CPPD目前的药理治疗方法的文献综述.
- 对急性和慢性炎症性关节炎的治疗方法的分析与CPPD相关.
- 包括关于新疗法及其疗效的数据.
主要成果:
- 无 NSAID,皮质类固醇和胆固醇对于急性 CPPD 关节炎发作是有效的.
- 科尔奇辛可以用于预防;anakinra是一种耐火火焰的选择.
- 慢性CPPD的治疗包括NSAIDs,科尔奇辛,化,低剂量葡萄糖皮质类药物,甲基和托西利祖马布用于耐火病例.
结论:
- 目前的CPPD管理主要针对症状和炎症,疾病修饰的选择有限.
- 基于证据的治疗方案受到缺乏强大的临床试验的阻碍.
- 需要进一步的研究来开发针对CPPD关节化的疗法.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
162
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
162
Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Peptic Ulcer Disease IV: Management
91
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
91
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K


